QL
TARS icon

Quarry LP’s Tarsus Pharmaceuticals TARS Stock Holding History

Quarry LP’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$252 Buy
+4
New +$256 ﹤0.01% 2262
2026
Q1 		– Sell
-2,400
Closed -$197K – 2217
2025
Q4 		$197K Sell
2,400
-3,700
-61% -$276K 0.03% 277
2025
Q3 		$363K Buy
6,100
+3,100
+103% +$153K 0.08% 229
2025
Q2 		$122K Sell
3,000
-599
-17% -$27K 0.03% 482
2025
Q1 		$185K Buy
3,599
+599
+20% +$29.6K 0.04% 320
2024
Q4 		$166K Buy
+3,000
New +$136K 0.02% 292

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Quarry LP's TARS Position: Q2 2026 in Review

Quarry LP opened a new position in Tarsus Pharmaceuticals (TARS) in Q2 2026: 4 shares worth $252. The stake represents ﹤0.01% of the portfolio and ranks #2262 among its holdings. This is a return to the name: Quarry LP previously reported a position in TARS as recently as Q4 2025.

Quarry LP first reported a position in TARS in Q4 2024 and has held it in 6 quarters since. The position peaked at $363K in Q3 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Quarry LP held 4 shares of Tarsus Pharmaceuticals worth $252 as of Q2 2026.
  • Tarsus Pharmaceuticals was a new Quarry LP position in Q2 2026.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #2262 holding.
  • Quarry LP first reported a position in Tarsus Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Quarry LP's Tarsus Pharmaceuticals position peaked at $363K in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.